Publication | Closed Access
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer
60
Citations
31
References
2016
Year
Pancreatic CancerGastrointestinal OncologyPhase I/ii StudyMedicinePharmacologyPathologyBay 86-9766Molecular OncologyAdvanced Pancreatic CancerCancer TreatmentOncologyRadiation OncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1